Can last week’s losers Anglo American plc (-15%), Inmarsat plc (-13%) and Ophir Energy plc (-10%) rebound?

Royston Wild considers whether Anglo American plc (LON: AAL), Inmarsat plc (LON: ISAT) and Ophir Energy plc (LON: OPHR) can bounce back.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at the investment prospects of three recent Footsie fallers.

Falling from orbit

Satellite builder Inmarsat (LSE: ISAT) took a heavy pasting from Monday-Friday after downgrading its revenues forecasts for the year.

Inmarsat commented that the “sustained recession in global maritime and energy markets continues” is forcing the business to cut its 2016 sales projections by $50m to $1.175bn-$1.25bn. The company saw total revenues slip 2% between January and March, to $298.6m.

Indeed, problems in the shipping and commodities markets are expected to drive earnings 22% lower in 2016 alone, resulting in a conventionally-high P/E rating of 24.5 times.

Although the mobile satellite services sector provides exciting growth opportunities for Inmarsat, I reckon the troubles washing across its other markets make the business an unattractive selection at present, particularly in view of its hefty share price.

Metals migraine

I have long argued that the recent surge in commodity prices — and with it the share values of many mining and energy producers — is in danger of a colossal retracement.

These advances have come in spite of extremely-poor supply and demand balances persisting across most commodity segments. So fresh signs of economic cooling in the US, allied with lasting fears over the health of China, have pushed stock values heavily to the downside in recent days.

Diversified digger Anglo American (LSE: AAL), for example, saw its share price slump by double-digit percentages last week, the firm toppling from recent eight-month highs just below 800p. And the business has slumped again in Monday business, this time by a chunky 8%, following bearish news surrounding the iron ore sector.

Prices of the steelmaking ingredient — a segment from which Anglo American generates a third of all earnings — have tanked in start-of-week trading after Bloomberg data showed stockpiles at Chinese ports rocketed to their highest since last April, at 92.2m tonnes.

With Anglo American’s other major markets also suffering from chronic oversupply, the City expects earnings to tank 32% in the current year alone. This projection leaves the digger dealing on a vast P/E rating of 23 times.

I believe Anglo American’s elevated multiple is unfathomable given the firm’s huge risk profile and lack of obvious growth drivers, and reckon the ratio leaves plenty of space for a hefty correction.

Driller dives

But Anglo American isn’t the only commodities stock in danger of a mammoth retracement. Indeed, I reckon fossil fuel producer Ophir Energy (LSE: OPHR) could also add to last week’s heavy losses as the oil industry heaves under excess supply.

The company’s massive risk profile went up another notch in late April after an accord with oil services provider Schlumberger went up in smoke. The pair had agreed to develop the Fortuna FNLG project in Equatorial Guinea, in a deal that would have given the US firm a 40% stake in the asset in return for covering half of Ophir’s previous costs.

Questions have now been raised over Ophir’s ability to fund the development of the project, not to mention the economic viability of the asset in the current climate.

The City already expects Ophir to keep punching losses until next year at the earliest. Given the company’s poor revenues outlook and rapidly-diminishing cash pile, I reckon investors should give the business short shrift.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »